Noah Medical, a San Carlos, California-based medical robotics innovator, raised $150M in Series B funding. Among the investors in the round were Hillhouse Capital, Sequoia Capital China, and UpHonest Capital. Softbank Vision Fund and Prosperity7 Ventures jointly led the round.
A month ago, the Food and Drug Administration (FDA) approved Noah Medical’s lung bronchoscopy equipment for commercial usage in the United States. The Galaxy system is a platform that slithers a robotic arm through the lung’s airways while scanning the tissue for cancer cells.
Clinical studies for the same device are currently being conducted in Australia. Noah Medical will use the money to address the growing demand for the Galaxy SystemTM, their advanced integrated guided robotic bronchoscopy system.
“Next-generation robotics platforms like the Galaxy System are filling procedural gaps to provide superior clinical values to serve customers’ needs better. We are excited to welcome these investors to the team and are eager to grow and serve even more patients and clinicians,” said Jian Zhang, Ph.D., Noah Medical founder and CEO.
Medical facilities can use the same instrument between patients more quickly thanks to Noah Medical’s disposable probes. Users may swap out the probe, saving time and allowing clinicians to examine more patients simultaneously without re-sanitizing the gadget.
Robotics is quickly making its way into the diagnostics
The Galaxy System is ready to upend the lung biopsy market thanks to its TiLT+TechnologyTM, integrated tomosynthesis, augmented fluoroscopy, single-use disposable bronchoscope, and small, compact footprint.
The technology had already been well-received by interventional pulmonologists who evaluated it over the previous year. The business recently declared it had started first-in-human trials at Sydney, Australia’s Macquarie University Hospital.
Robotics has advanced swiftly in the diagnostics field, but bronchoscopy technology has lagged in the area of pulmonology. Many of these must perform the functions of an all-in-one medical imaging gadget. Overworked nurses and doctors are less inclined to adopt them if they don’t have a small, compact footprint and are simple to operate.
Noah Medical is creating the medical robotics of the future. The company aims to improve patient quality of life internationally by providing adaptable clinical solutions using cutting-edge endoluminal technologies. The Galaxy System is Noah Medical’s first commercial robotic system.
